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innovations, with regard to their impact on patients’ health status. RESULTS: Response 
rate was 78%. The seven most important pharmaceutical innovations reported were 
Angiotensin Converting Enzyme (ACE) inhibitors and angiotensin II antagonists, inhaled 
steroids and β2-agonists, statins, proton pump inhibitors and H2-antagonists, novel 
antibiotics, antiviral drugs for hepatitis  and C and calcium channel blockers. The seven 
most important technological innovations were: magnetic resonance imaging (MRI) and 
computed tomography scanning (CT), balloon angioplasty with stents, Coronary Artery 
Bypass Graft (CABG), gastrointestinal endoscopy, Human Immunodeﬁ ciency Virus 
testing, mammography and Prostate-Speciﬁ c Antigen (PSA) testing. In both cases, inno-
vations that ranked higher were used to treat high-prevalence diseases with a signiﬁ cant 
contribution on the burden of disease for the Greek population. In addition, innovations 
that contributed to improvements in disease diagnoses and management were also 
ranked higher. CONCLUSIONS: the epidemiological proﬁ le of the population, the 
effectiveness of each innovation in terms of clinical effectiveness as well as health-related 
quality of life, and the utility of the innovation in everyday clinical practice constitute 
important determinants of the physicians’ opinions regarding the relative importance of 
medical innovations on the health status of the Greek population.
PHP111
PREDICTING PREVENTIVE CARE SERVICE UTILIZATION IN A UNITED 
STATES POPULATION
Partha G1, Vaidya V1, Howe J2, Ferrell M1
1University of Toledo, Toledo, OH, USA; 2The University of Toledo, Toledo, OH, USA
OBJECTIVES: To analyze and predict trends in utilization of preventive care services 
in a United States population using a national database. Several national reports and 
evidence in literature indicate disparities in the utilization of preventive care services 
but only few have predicted utilization patterns of preventive care services. METHODS: 
The 2007 Medical Expenditure Panel Survey (MEPS), a national probability sample 
survey of the ambulatory civilian US population, was analyzed to determine demo-
graphic patterns of utilization. Utilization of blood pressure screening, cancer screen-
ing (mammography, colonoscopy/sigmoidoscopy, pap smear and breast), cholesterol 
and dental checkup and ﬂ u vaccination were used as the dependent variables while 
age, gender, race/ ethnicity, annual income insurance status and perceived health status 
were used as independent variables. Descriptive statistics were used to describe the 
population; univariate chi-squared analysis was used to determine group differences 
for the categorical variables. Multivariate logistic regression model was built to predict 
odds of utilization of services. All analyses were carried out using SAS v9.1. RESULTS: 
Utilization of preventive care services was found to be high for blood pressure (n = 
17,959, 89.0%) and cholesterol (n = 14,956, 94.7%) checkup and low for ﬂ u vaccina-
tion (n = 30,964, 21.2%). Signiﬁ cant chi square differences in utilization of preventive 
care services were found for most of the dependent variables (P < 0.001), save for 
colonoscopy/sigmoidoscopy screening. Regression model showed that young women 
(20–30 years) with higher income were more likely to obtain breast exams (OR = 
10.584; CI = 4.312–25.980) compared with young women earning lower income 
(<$20,000). Odds of utilization were nearly similar for all races. However, Hispanics 
were more likely to obtain a colonoscopy/sigmoidoscopy (OR = 3.069; CI = 2.216–
4.250) compared with non-Hispanics. The uninsured generally had lower odds of 
utilization across almost all preventive care services. CONCLUSIONS: This study was 
successful in identifying age, race, income and insurance status-related disparities and 
in predicting preventive care service utilization in a US population. 
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OBJECTIVES: To evaluate the number and types of pharmacists’ interventions of 
electronic prescriptions at Sultan Qaboos University (SQU) hospital in Oman. 
METHODS: This was a prospective study where interventions on electronic prescrip-
tions over one-year (2009) at SQU hospital were evaluated. a standard data collection 
form was used to capture the data related to drug choice and drug regimen. Clinical 
relevance was deﬁ ned as to whether efﬁ cacy or toxicity was either improved or 
reduced. Clinical relevance was based on the judgments of at least two pharmacists. 
Analyses were performed using descriptive statistics. RESULTS: A total of 1,123 
interventions were recorded out of 186,353 prescriptions (intervention rate/prescrip-
tion = 0.6%) and 454,654 items (intervention rate/item = 0.25%) dispensed. During 
the year, only 3% of the interventions were administrative (absence of doctor’s sig-
nature/wrong patient’s card) while 97% were clinical. The clinical interventions were 
categorized into drug regimen (n = 886; 74%) and drug choice (n = 313; 26%). Almost 
62% (n = 547) of the problems associated with drug regimen were related to wrong 
doses. The three most common drug choice issues included wrong formulations (n = 
107; 34%), wrong drug (n = 62; 20%) and deletion (n = 62; 20%). Efﬁ cacy improved 
in 52% (n = 588) of the cases, avoided toxicity in 29% (n = 324) and avoided unneces-
sary exposure in 19% (n = 211). Interventions prevented organ damage in 1.7% (n = 
20) of the cases, major in 17% (n = 188), moderate in 49% (n = 550) and minor in 
32% (n = 364). The mean time (±SD) spent per prescription was 11 ± 9 minutes. 
CONCLUSIONS: The data show that out-patient pharmacists play an important role 
in drug safety and optimization of pharmaceutical care.
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OBJECTIVES: Adequate levels of medication are critical among elderly patients given 
the existence of co-morbidities and impaired levels of functioning. Using patient data 
collected via a web-based information system, we investigated the average number of 
items prescribed to geriatric patients treated in Acute Geriatric and Remobilisation 
Units (AG/R) in Austria between January 2008 and December 2009. We investigated 
the association of age with medication levels and assessed whether treatment in an 
AG/R led to changes in levels of medication. METHODS: The standardised data set 
developed by QiGG was made available by AG/Rs using the geriatric module of the 
online information system “Healthgate BARS”. We assessed patients’ medication data 
including number of prescribed items at admission and discharge. Baseline character-
istics (including age) were assessed. Additionally, changes in medication prescriptions 
during the stay were documented. RESULTS: Data from 14,923 stays were analyzed. 
Patients were prescribed a mean of 8.4 agents (±3.6) at admission which was signiﬁ -
cantly reduced to a mean of 8.0 (±3.35) at discharge after a mean length of stay of 
18.9 (±14.1) days. a reduction in levels of medication was observed among all age 
groups (young-old: −74, middle-old: 75–84, oldest-old: 85+).The oldest old had the 
lowest mean number of prescriptions at both admission (8.1 ± 3.4) and discharge (7.6 
± 3.1). There was an overall increase in documented changes to prescriptions (either 
in number or type of medications) during this period from 61.1% to 80.1%. CON-
CLUSIONS: The observed reductions in levels of medication across all analyzed 
groups during (in-patient) stays in AG/Rs, as well as the documented changes in 
prescriptions, may suggest increased awareness both of over-prescription and the 
necessity of adequate medication levels in special geriatric care.
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OBJECTIVES: Both observed and unobserved bias in observational claims data are 
controlled with instrumental variable approach. However, it is difﬁ cult to ﬁ nd a valid 
instrument that is strongly correlated with treatment choice but not directly correlated 
with outcomes. In this paper, we derived doctors’ prescribing patterns from the claims 
data and examined their validity. METHODS: Based on U.S. claims data, we assigned 
patients a unique doctor based on the greatest number of ofﬁ ce visits during the 6 
months pre-index period. For each physician, and for each 6-month calendar block 
of time, we estimated the physician preference as the time-varying proportion of 
patients treated with selective serotonin reuptake inhibitors (SSRIs) and serotonin–
norepinephrine reuptake inhibitors (SNRIs) during that interval. We applied Shea’s 
partial R-square method, the Anderson canonical correlation, and Cragg-Donald tests 
to check if doctors’ prescribing patterns were weak instruments. RESULTS: Tests 
showed that doctors’ prescribing patterns are a valid and strong instrument for out-
comes research studies. We showed that patients were more likely to be prescribed 
generic SSRIs relative to non-generic SSRIs if doctors’ prescribing patterns favored 
generic prescription (p = 0.000). Similarly, patients were less likely to be in the SSRIs 
group if doctors’ prescribing patterns favored SNRI prescriptions (p = 0.000). We 
showed that the treatment coefﬁ cient on the adherence model that does not control 
for the unobserved bias was 10% lower than the one that uses the instrumental vari-
able method. CONCLUSIONS: Doctors’ prescribing patterns are important factors 
for prescription decisions. Any outcomes research models such as compliance, adher-
ence or treatment effect studies should incorporate these patterns. Models that fail to 
control for these variables might contain omitted variable bias.
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OBJECTIVES: Because economic evaluations aim to decrease practice variations and 
advocate (cost)-effective interventions, their use in the formulation of practice 
